← 產業報告目錄
Procalcitonin Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-08頁數 132報告編號 APO-029874bfde
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.
Report Scope
This report quantifies the global Procalcitonin market in terms of revenue (US$ million) and, where applicable, sales volume (mg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/mg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Procalcitonin Market by Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
Procalcitonin Segment by Type
Procalcitonin Antigen
Procalcitonin Antibody
Procalcitonin Segment by Application
Medical Industry
Scientific Research
Veterinarian
Procalcitonin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Procalcitonin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Procalcitonin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Procalcitonin Market Size (2021-2032)
2.2.2 Global Procalcitonin Sales (2021-2032)
2.2.3 Global Procalcitonin Market Average Price (2021-2032)
2.3 Procalcitonin by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Procalcitonin Antigen
2.3.3 Procalcitonin Antibody
2.4 Procalcitonin by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Medical Industry
2.4.3 Scientific Research
2.4.4 Veterinarian
3 Market Competitive Landscape by Manufacturers
3.1 Global Procalcitonin Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Procalcitonin Sales (mg) of Manufacturers (2021-2026)
3.3 Global Procalcitonin Revenue of Manufacturers (2021-2026)
3.4 Global Procalcitonin Average Price by Manufacturers (2021-2026)
3.5 Global Procalcitonin Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Procalcitonin, Product Type & Application
3.8 Global Manufacturers of Procalcitonin, Established Date
3.9 Global Procalcitonin Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Thermo Fisher
4.1.1 Thermo Fisher Company Information
4.1.2 Thermo Fisher Business Overview
4.1.3 Thermo Fisher Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Thermo Fisher Procalcitonin Product Portfolio
4.1.5 Thermo Fisher Recent Developments
4.2 Roche Diagnostics
4.2.1 Roche Diagnostics Company Information
4.2.2 Roche Diagnostics Business Overview
4.2.3 Roche Diagnostics Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Roche Diagnostics Procalcitonin Product Portfolio
4.2.5 Roche Diagnostics Recent Developments
4.3 bioMerieux
4.3.1 bioMerieux Company Information
4.3.2 bioMerieux Business Overview
4.3.3 bioMerieux Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.3.4 bioMerieux Procalcitonin Product Portfolio
4.3.5 bioMerieux Recent Developments
4.4 HyTest
4.4.1 HyTest Company Information
4.4.2 HyTest Business Overview
4.4.3 HyTest Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.4.4 HyTest Procalcitonin Product Portfolio
4.4.5 HyTest Recent Developments
4.5 BBI Solutions
4.5.1 BBI Solutions Company Information
4.5.2 BBI Solutions Business Overview
4.5.3 BBI Solutions Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.5.4 BBI Solutions Procalcitonin Product Portfolio
4.5.5 BBI Solutions Recent Developments
4.6 ProSpec
4.6.1 ProSpec Company Information
4.6.2 ProSpec Business Overview
4.6.3 ProSpec Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.6.4 ProSpec Procalcitonin Product Portfolio
4.6.5 ProSpec Recent Developments
4.7 Wondfo
4.7.1 Wondfo Company Information
4.7.2 Wondfo Business Overview
4.7.3 Wondfo Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Wondfo Procalcitonin Product Portfolio
4.7.5 Wondfo Recent Developments
4.8 Ningbo Medicalsystem Biotechnology
4.8.1 Ningbo Medicalsystem Biotechnology Company Information
4.8.2 Ningbo Medicalsystem Biotechnology Business Overview
4.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
4.8.5 Ningbo Medicalsystem Biotechnology Recent Developments
4.9 Wuhan Easy Diagnosis Biomedicine
4.9.1 Wuhan Easy Diagnosis Biomedicine Company Information
4.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
4.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
4.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
4.10 Snibe
4.10.1 Snibe Company Information
4.10.2 Snibe Business Overview
4.10.3 Snibe Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Snibe Procalcitonin Product Portfolio
4.10.5 Snibe Recent Developments
4.11 Vazyme Biotech
4.11.1 Vazyme Biotech Company Information
4.11.2 Vazyme Biotech Business Overview
4.11.3 Vazyme Biotech Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Vazyme Biotech Procalcitonin Product Portfolio
4.11.5 Vazyme Biotech Recent Developments
4.12 Getein Biotech
4.12.1 Getein Biotech Company Information
4.12.2 Getein Biotech Business Overview
4.12.3 Getein Biotech Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Getein Biotech Procalcitonin Product Portfolio
4.12.5 Getein Biotech Recent Developments
4.13 Hotgen Biotech
4.13.1 Hotgen Biotech Company Information
4.13.2 Hotgen Biotech Business Overview
4.13.3 Hotgen Biotech Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Hotgen Biotech Procalcitonin Product Portfolio
4.13.5 Hotgen Biotech Recent Developments
4.14 Lumigenex
4.14.1 Lumigenex Company Information
4.14.2 Lumigenex Business Overview
4.14.3 Lumigenex Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Lumigenex Procalcitonin Product Portfolio
4.14.5 Lumigenex Recent Developments
4.15 Nanjing Norman Biological Technology
4.15.1 Nanjing Norman Biological Technology Company Information
4.15.2 Nanjing Norman Biological Technology Business Overview
4.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
4.15.5 Nanjing Norman Biological Technology Recent Developments
4.16 Kitgen
4.16.1 Kitgen Company Information
4.16.2 Kitgen Business Overview
4.16.3 Kitgen Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.16.4 Kitgen Procalcitonin Product Portfolio
4.16.5 Kitgen Recent Developments
4.17 Beijing KeyGen
4.17.1 Beijing KeyGen Company Information
4.17.2 Beijing KeyGen Business Overview
4.17.3 Beijing KeyGen Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Beijing KeyGen Procalcitonin Product Portfolio
4.17.5 Beijing KeyGen Recent Developments
4.18 Beijing Apis
4.18.1 Beijing Apis Company Information
4.18.2 Beijing Apis Business Overview
4.18.3 Beijing Apis Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
4.18.4 Beijing Apis Procalcitonin Product Portfolio
4.18.5 Beijing Apis Recent Developments
5 Global Procalcitonin Market Scenario by Region
5.1 Global Procalcitonin Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Procalcitonin Sales by Region: 2021-2032
5.2.1 Global Procalcitonin Sales by Region: 2021-2026
5.2.2 Global Procalcitonin Sales by Region: 2027-2032
5.3 Global Procalcitonin Revenue by Region: 2021-2032
5.3.1 Global Procalcitonin Revenue by Region: 2021-2026
5.3.2 Global Procalcitonin Revenue by Region: 2027-2032
5.4 North America Procalcitonin Market Facts & Figures by Country
5.4.1 North America Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Procalcitonin Sales by Country (2021-2032)
5.4.3 North America Procalcitonin Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Procalcitonin Market Facts & Figures by Country
5.5.1 Europe Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Procalcitonin Sales by Country (2021-2032)
5.5.3 Europe Procalcitonin Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Procalcitonin Market Facts & Figures by Country
5.6.1 Asia Pacific Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Procalcitonin Sales by Country (2021-2032)
5.6.3 Asia Pacific Procalcitonin Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Procalcitonin Market Facts & Figures by Country
5.7.1 South America Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Procalcitonin Sales by Country (2021-2032)
5.7.3 South America Procalcitonin Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Procalcitonin Market Facts & Figures by Country
5.8.1 Middle East and Africa Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Procalcitonin Sales by Country (2021-2032)
5.8.3 Middle East and Africa Procalcitonin Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Procalcitonin Sales by Type (2021-2032)
6.1.1 Global Procalcitonin Sales by Type (2021-2032) & (mg)
6.1.2 Global Procalcitonin Sales Market Share by Type (2021-2032)
6.2 Global Procalcitonin Revenue by Type (2021-2032)
6.2.1 Global Procalcitonin Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Procalcitonin Revenue Market Share by Type (2021-2032)
6.3 Global Procalcitonin Price by Type (2021-2032)
7 Segment by Application
7.1 Global Procalcitonin Sales by Application (2021-2032)
7.1.1 Global Procalcitonin Sales by Application (2021-2032) & (mg)
7.1.2 Global Procalcitonin Sales Market Share by Application (2021-2032)
7.2 Global Procalcitonin Revenue by Application (2021-2032)
7.2.1 Global Procalcitonin Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Procalcitonin Revenue Market Share by Application (2021-2032)
7.3 Global Procalcitonin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Procalcitonin Value Chain Analysis
8.1.1 Procalcitonin Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Procalcitonin Production Mode & Process
8.2 Procalcitonin Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Procalcitonin Distributors
8.2.3 Procalcitonin Customers
9 Global Procalcitonin Analyzing Market Dynamics
9.1 Procalcitonin Industry Trends
9.2 Procalcitonin Industry Drivers
9.3 Procalcitonin Industry Opportunities and Challenges
9.4 Procalcitonin Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Procalcitonin Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Procalcitonin Sales (mg) of Manufacturers (2021-2026)
Table 7. Global Procalcitonin Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Procalcitonin Revenue of Manufacturers (2021-2026)
Table 9. Global Procalcitonin Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Procalcitonin Average Price (USD/mg) of Manufacturers (2021-2026)
Table 11. Global Procalcitonin Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Procalcitonin, Product Type & Application
Table 14. Global Procalcitonin Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Procalcitonin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Thermo Fisher Company Information
Table 19. Thermo Fisher Business Overview
Table 20. Thermo Fisher Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 21. Thermo Fisher Procalcitonin Product Portfolio
Table 22. Thermo Fisher Recent Developments
Table 23. Roche Diagnostics Company Information
Table 24. Roche Diagnostics Business Overview
Table 25. Roche Diagnostics Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 26. Roche Diagnostics Procalcitonin Product Portfolio
Table 27. Roche Diagnostics Recent Developments
Table 28. bioMerieux Company Information
Table 29. bioMerieux Business Overview
Table 30. bioMerieux Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 31. bioMerieux Procalcitonin Product Portfolio
Table 32. bioMerieux Recent Developments
Table 33. HyTest Company Information
Table 34. HyTest Business Overview
Table 35. HyTest Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 36. HyTest Procalcitonin Product Portfolio
Table 37. HyTest Recent Developments
Table 38. BBI Solutions Company Information
Table 39. BBI Solutions Business Overview
Table 40. BBI Solutions Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 41. BBI Solutions Procalcitonin Product Portfolio
Table 42. BBI Solutions Recent Developments
Table 43. ProSpec Company Information
Table 44. ProSpec Business Overview
Table 45. ProSpec Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 46. ProSpec Procalcitonin Product Portfolio
Table 47. ProSpec Recent Developments
Table 48. Wondfo Company Information
Table 49. Wondfo Business Overview
Table 50. Wondfo Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 51. Wondfo Procalcitonin Product Portfolio
Table 52. Wondfo Recent Developments
Table 53. Ningbo Medicalsystem Biotechnology Company Information
Table 54. Ningbo Medicalsystem Biotechnology Business Overview
Table 55. Ningbo Medicalsystem Biotechnology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 56. Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
Table 57. Ningbo Medicalsystem Biotechnology Recent Developments
Table 58. Wuhan Easy Diagnosis Biomedicine Company Information
Table 59. Wuhan Easy Diagnosis Biomedicine Business Overview
Table 60. Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 61. Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
Table 62. Wuhan Easy Diagnosis Biomedicine Recent Developments
Table 63. Snibe Company Information
Table 64. Snibe Business Overview
Table 65. Snibe Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 66. Snibe Procalcitonin Product Portfolio
Table 67. Snibe Recent Developments
Table 68. Vazyme Biotech Company Information
Table 69. Vazyme Biotech Business Overview
Table 70. Vazyme Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 71. Vazyme Biotech Procalcitonin Product Portfolio
Table 72. Vazyme Biotech Recent Developments
Table 73. Getein Biotech Company Information
Table 74. Getein Biotech Business Overview
Table 75. Getein Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 76. Getein Biotech Procalcitonin Product Portfolio
Table 77. Getein Biotech Recent Developments
Table 78. Hotgen Biotech Company Information
Table 79. Hotgen Biotech Business Overview
Table 80. Hotgen Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 81. Hotgen Biotech Procalcitonin Product Portfolio
Table 82. Hotgen Biotech Recent Developments
Table 83. Lumigenex Company Information
Table 84. Lumigenex Business Overview
Table 85. Lumigenex Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 86. Lumigenex Procalcitonin Product Portfolio
Table 87. Lumigenex Recent Developments
Table 88. Nanjing Norman Biological Technology Company Information
Table 89. Nanjing Norman Biological Technology Business Overview
Table 90. Nanjing Norman Biological Technology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 91. Nanjing Norman Biological Technology Procalcitonin Product Portfolio
Table 92. Nanjing Norman Biological Technology Recent Developments
Table 93. Kitgen Company Information
Table 94. Kitgen Business Overview
Table 95. Kitgen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 96. Kitgen Procalcitonin Product Portfolio
Table 97. Kitgen Recent Developments
Table 98. Beijing KeyGen Company Information
Table 99. Beijing KeyGen Business Overview
Table 100. Beijing KeyGen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 101. Beijing KeyGen Procalcitonin Product Portfolio
Table 102. Beijing KeyGen Recent Developments
Table 103. Beijing Apis Company Information
Table 104. Beijing Apis Business Overview
Table 105. Beijing Apis Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026)
Table 106. Beijing Apis Procalcitonin Product Portfolio
Table 107. Beijing Apis Recent Developments
Table 108. Global Procalcitonin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 109. Global Procalcitonin Sales by Region (2021-2026) & (mg)
Table 110. Global Procalcitonin Sales Market Share by Region (2021-2026)
Table 111. Global Procalcitonin Sales by Region (2027-2032) & (mg)
Table 112. Global Procalcitonin Sales Market Share by Region (2027-2032)
Table 113. Global Procalcitonin Revenue by Region (2021-2026) & (US$ Million)
Table 114. Global Procalcitonin Revenue Market Share by Region (2021-2026)
Table 115. Global Procalcitonin Revenue by Region (2027-2032) & (US$ Million)
Table 116. Global Procalcitonin Revenue Market Share by Region (2027-2032)
Table 117. North America Procalcitonin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. North America Procalcitonin Sales by Country (2021-2026) & (mg)
Table 119. North America Procalcitonin Sales by Country (2027-2032) & (mg)
Table 120. North America Procalcitonin Revenue by Country (2021-2026) & (US$ Million)
Table 121. North America Procalcitonin Revenue by Country (2027-2032) & (US$ Million)
Table 122. Europe Procalcitonin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Europe Procalcitonin Sales by Country (2021-2026) & (mg)
Table 124. Europe Procalcitonin Sales by Country (2027-2032) & (mg)
Table 125. Europe Procalcitonin Revenue by Country (2021-2026) & (US$ Million)
Table 126. Europe Procalcitonin Revenue by Country (2027-2032) & (US$ Million)
Table 127. Asia Pacific Procalcitonin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Asia Pacific Procalcitonin Sales by Country (2021-2026) & (mg)
Table 129. Asia Pacific Procalcitonin Sales by Country (2027-2032) & (mg)
Table 130. Asia Pacific Procalcitonin Revenue by Country (2021-2026) & (US$ Million)
Table 131. Asia Pacific Procalcitonin Revenue by Country (2027-2032) & (US$ Million)
Table 132. South America Procalcitonin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. South America Procalcitonin Sales by Country (2021-2026) & (mg)
Table 134. South America Procalcitonin Sales by Country (2027-2032) & (mg)
Table 135. South America Procalcitonin Revenue by Country (2021-2026) & (US$ Million)
Table 136. South America Procalcitonin Revenue by Country (2027-2032) & (US$ Million)
Table 137. Middle East and Africa Procalcitonin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. Middle East and Africa Procalcitonin Sales by Country (2021-2026) & (mg)
Table 139. Middle East and Africa Procalcitonin Sales by Country (2027-2032) & (mg)
Table 140. Middle East and Africa Procalcitonin Revenue by Country (2021-2026) & (US$ Million)
Table 141. Middle East and Africa Procalcitonin Revenue by Country (2027-2032) & (US$ Million)
Table 142. Global Procalcitonin Sales by Type (2021-2026) & (mg)
Table 143. Global Procalcitonin Sales by Type (2027-2032) & (mg)
Table 144. Global Procalcitonin Sales Market Share by Type (2021-2026)
Table 145. Global Procalcitonin Sales Market Share by Type (2027-2032)
Table 146. Global Procalcitonin Revenue by Type (2021-2026) & (US$ Million)
Table 147. Global Procalcitonin Revenue by Type (2027-2032) & (US$ Million)
Table 148. Global Procalcitonin Revenue Market Share by Type (2021-2026)
Table 149. Global Procalcitonin Revenue Market Share by Type (2027-2032)
Table 150. Global Procalcitonin Price by Type (2021-2026) & (USD/mg)
Table 151. Global Procalcitonin Price by Type (2027-2032) & (USD/mg)
Table 152. Global Procalcitonin Sales by Application (2021-2026) & (mg)
Table 153. Global Procalcitonin Sales by Application (2027-2032) & (mg)
Table 154. Global Procalcitonin Sales Market Share by Application (2021-2026)
Table 155. Global Procalcitonin Sales Market Share by Application (2027-2032)
Table 156. Global Procalcitonin Revenue by Application (2021-2026) & (US$ Million)
Table 157. Global Procalcitonin Revenue by Application (2027-2032) & (US$ Million)
Table 158. Global Procalcitonin Revenue Market Share by Application (2021-2026)
Table 159. Global Procalcitonin Revenue Market Share by Application (2027-2032)
Table 160. Global Procalcitonin Price by Application (2021-2026) & (USD/mg)
Table 161. Global Procalcitonin Price by Application (2027-2032) & (USD/mg)
Table 162. Key Raw Materials
Table 163. Raw Materials Key Suppliers
Table 164. Procalcitonin Distributors List
Table 165. Procalcitonin Customers List
Table 166. Procalcitonin Industry Trends
Table 167. Procalcitonin Industry Drivers
Table 168. Procalcitonin Industry Restraints
Table 169. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Procalcitonin Product Image
Figure 5. Global Procalcitonin Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Procalcitonin Market Size (2021-2032) & (US$ Million)
Figure 7. Global Procalcitonin Sales (2021-2032) & (mg)
Figure 8. Global Procalcitonin Average Price (USD/mg) & (2021-2032)
Figure 9. Procalcitonin Antigen Product Image
Figure 10. Procalcitonin Antibody Product Image
Figure 11. Medical Industry Product Image
Figure 12. Scientific Research Product Image
Figure 13. Veterinarian Product Image
Figure 14. Global Procalcitonin Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Procalcitonin Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Procalcitonin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Procalcitonin Sales by Region in 2025
Figure 20. Global Procalcitonin Revenue by Region in 2025
Figure 21. North America Procalcitonin Market Size by Country in 2025
Figure 22. North America Procalcitonin Sales Market Share by Country (2021-2032)
Figure 23. North America Procalcitonin Revenue Market Share by Country (2021-2032)
Figure 24. United States Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Mexico Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Procalcitonin Market Size by Country in 2025
Figure 28. Europe Procalcitonin Sales Market Share by Country (2021-2032)
Figure 29. Europe Procalcitonin Revenue Market Share by Country (2021-2032)
Figure 30. Germany Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Russia Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Spain Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Netherlands Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Switzerland Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Sweden Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Poland Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Asia Pacific Procalcitonin Market Size by Country in 2025
Figure 41. Asia Pacific Procalcitonin Sales Market Share by Country (2021-2032)
Figure 42. Asia Pacific Procalcitonin Revenue Market Share by Country (2021-2032)
Figure 43. China Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Japan Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. South Korea Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. India Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Australia Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Taiwan Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. South America Procalcitonin Market Size by Country in 2025
Figure 52. South America Procalcitonin Sales Market Share by Country (2021-2032)
Figure 53. South America Procalcitonin Revenue Market Share by Country (2021-2032)
Figure 54. Brazil Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Argentina Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Chile Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Middle East and Africa Procalcitonin Market Size by Country in 2025
Figure 58. Middle East and Africa Procalcitonin Sales Market Share by Country (2021-2032)
Figure 59. Middle East and Africa Procalcitonin Revenue Market Share by Country (2021-2032)
Figure 60. Egypt Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. South Africa Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Israel Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Türkiye Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. GCC Countries Procalcitonin Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Global Procalcitonin Sales Market Share by Type (2021-2032)
Figure 66. Global Procalcitonin Revenue Market Share by Type (2021-2032)
Figure 67. Global Procalcitonin Price (USD/mg) by Type (2021-2032)
Figure 68. Global Procalcitonin Sales Market Share by Application (2021-2032)
Figure 69. Global Procalcitonin Revenue Market Share by Application (2021-2032)
Figure 70. Global Procalcitonin Price (USD/mg) by Application (2021-2032)
Figure 71. Procalcitonin Value Chain
Figure 72. Procalcitonin Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Procalcitonin Industry Opportunities and Challenges
提及公司
Thermo FisherRoche DiagnosticsbioMerieuxHyTestBBI SolutionsProSpecWondfoNingbo Medicalsystem BiotechnologyWuhan Easy Diagnosis BiomedicineSnibeVazyme BiotechGetein BiotechHotgen BiotechLumigenexNanjing Norman Biological TechnologyKitgenBeijing KeyGenBeijing Apis
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們